Literature DB >> 16763017

Genetic variability, haplotype structures, and ethnic diversity of hepatic transporters MDR3 (ABCB4) and bile salt export pump (ABCB11).

Thomas Lang1, Michael Haberl, Diana Jung, Anja Drescher, Robert Schlagenhaufer, Andrea Keil, Esther Mornhinweg, Bruno Stieger, Gerd A Kullak-Ublick, Reinhold Kerb.   

Abstract

Biliary excretion of bile salts and other bile constituents from hepatocytes is mediated by the apical (canalicular) transporters P-glycoprotein 3 (MDR3, ABCB4) and the bile salt export pump (ABCB11). Mutations in ABCB4 and ABCB11 contribute to cholestatic diseases [e.g., progressive familial intrahepatic cholestasis 2 (PFIC2), PFIC3, and intrahepatic cholestasis of pregnancy], and our objective was to establish genetic variability and haplotype structures of ABCB4 and ABCB11 in healthy populations of different ethnic backgrounds. All coding exons, 5 of 6 noncoding exons, 50 to 300 base pairs of the flanking intronic regions, and 2.5 to 2.8 kilobase pairs of the promoter regions of ABCB4 and ABCB11 were sequenced in 159 and 196 DNA samples of Caucasian, African-American, Japanese, and Korean origin. In total, 76 and 86 polymorphisms were identified in ABCB4 and ABCB11, respectively; among them, 14 and 28 exonic polymorphisms, and 8 and 10 protein-altering variants, of which 4 were predicted to have functional consequences. Both genes showed substantial ethnic differences with respect to allele number, frequency of common and population-specific sites, and patterns of linkage disequilibrium. Population genetic analysis suggested some selective pressure against changes in the protein, supporting the important endogenous role of these transporters. Haplotype variability was greater in ABCB11 than in ABCB4. An ABCB11 promoter haplotype was associated with significant decrease of activity compared with wild type. Our results contribute to a better understanding of the molecular basis and of ethnic differences in drug response, and provide a valuable tool for future research on the heredity of cholestatic liver injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16763017     DOI: 10.1124/dmd.105.008854

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  24 in total

1.  Common variants at the GCK, GCKR, G6PC2-ABCB11 and MTNR1B loci are associated with fasting glucose in two Asian populations.

Authors:  F Takeuchi; T Katsuya; S Chakrewarthy; K Yamamoto; A Fujioka; M Serizawa; T Fujisawa; E Nakashima; K Ohnaka; H Ikegami; T Sugiyama; T Nabika; A Kasturiratne; S Yamaguchi; S Kono; R Takayanagi; Y Yamori; S Kobayashi; T Ogihara; A de Silva; R Wickremasinghe; N Kato
Journal:  Diabetologia       Date:  2009-11-25       Impact factor: 10.122

Review 2.  Drug-induced cholestasis.

Authors:  Manmeet S Padda; Mayra Sanchez; Abbasi J Akhtar; James L Boyer
Journal:  Hepatology       Date:  2011-04       Impact factor: 17.425

3.  Hepatic overexpression of abcb11 promotes hypercholesterolemia and obesity in mice.

Authors:  Anne S Henkel; Mark H Kavesh; Michael S Kriss; Amanda M Dewey; Mary E Rinella; Richard M Green
Journal:  Gastroenterology       Date:  2011-07-02       Impact factor: 22.682

4.  Analysis of gene mutations in children with cholestasis of undefined etiology.

Authors:  Ursula Matte; Reena Mourya; Alexander Miethke; Cong Liu; Gregory Kauffmann; Katie Moyer; Kejian Zhang; Jorge A Bezerra
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-10       Impact factor: 2.839

5.  Multidrug resistance protein 3 R652G may reduce susceptibility to idiopathic infant cholestasis.

Authors:  Xiu-Qi Chen; Lin-Lin Wang; Qing-Wen Shan; Qing Tang; Shu-Jun Lian
Journal:  World J Gastroenterol       Date:  2009-12-14       Impact factor: 5.742

Review 6.  Review of a challenging clinical issue: Intrahepatic cholestasis of pregnancy.

Authors:  Sebiha Ozkan; Yasin Ceylan; Orhan Veli Ozkan; Sule Yildirim
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

Review 7.  The bile salt export pump: clinical and experimental aspects of genetic and acquired cholestatic liver disease.

Authors:  Ping Lam; Carol J Soroka; James L Boyer
Journal:  Semin Liver Dis       Date:  2010-04-26       Impact factor: 6.115

8.  Polymorphic variants in the human bile salt export pump (BSEP; ABCB11): functional characterization and interindividual variability.

Authors:  Richard H Ho; Brenda F Leake; Dawn M Kilkenny; Henriette E Meyer Zu Schwabedissen; Hartmut Glaeser; Deanna L Kroetz; Richard B Kim
Journal:  Pharmacogenet Genomics       Date:  2010-01       Impact factor: 2.089

Review 9.  Bile acid transporters in health and disease.

Authors:  A Kosters; S J Karpen
Journal:  Xenobiotica       Date:  2008-07       Impact factor: 1.908

Review 10.  Biosynthesis and trafficking of the bile salt export pump, BSEP: therapeutic implications of BSEP mutations.

Authors:  Carol J Soroka; James L Boyer
Journal:  Mol Aspects Med       Date:  2013-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.